TheraXyte BioScience
PrivateLast Round
Seed
Jul 11, 2022
Total Funding Raised
$10M
Company Overview
TheraXyte BioScience is a biotechnology company that develops an extracellular vesicle (EV)-mediated drug delivery platform and EV-based novel therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TheraXyte BioScience Comparables
Compare TheraXyte BioScience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evox Therapeutics | 81% | |
| ILIAS Biologics Inc. | 81% | |
| EXO Biologics | 80% | |
TheraXyte BioScience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 11, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2026
Monthly visitors increased 2249% MoM, from 37 to 869.
- Jul 11, 2022
$10M round led by NHH Venture Fund, L.P.
TheraXyte BioScience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TheraXyte BioScience's valuation, stock price, and market status.